On 4 May 2020, the European Commission announced in a press release the reprioritisation of the Horizon 2020 framework programme funding. To help reach the objectives of the Coronavirus Global Response, €1 billion will be invested to fight the COVID-19 pandemic. It will fund global research on vaccines:
- €400 million for developing scientific solutions and health systems
- €400 million to finance Research and Developments investments
- €150 million for the European Innovation Council’s Accelerator
Learn more about it here.
If you are interested in funding opportunities in relation to Coronavirus, both at the European Union level and the national level, the European Research and Area and Corona Platform offers up-to-date information about Horizon 2020 calls and deadline extensions related to COVID-19 funded and ongoing projects.